Home


Login | Forgot password?
December 2, 2016
A new path to hope

Brainsgate is a medical device company committed to developing a novel treatment modality, electrical SPG stimulation. This platform technology has been shown to increase blood flow to the brain and as a result has broad potential for treating central nervous system disorders. BrainsGate is currently focusing on improving the outcome of patients suffering from ischemic stroke, in a 24 hour window after onset of symptoms.


Focus: the spheno-palatine ganglion
Two small nervous centers located above the roof of the mouth near the sinuses read more
Focus: ISS
BrainsGate's product for the treatment of ischemic stroke and vascular dementia read more
July 16, 2014
ImpACT24 Interim Results
The Data Safety Monitoring Board (the "DSMB") for BrainsGate's study examined the interim results and deterimined the results support the continuation of the study > full story
January 1, 1970
> full story